Cargando…
The public health value of vaccines beyond efficacy: methods, measures and outcomes
BACKGROUND: Assessments of vaccine efficacy and safety capture only the minimum information needed for regulatory approval, rather than the full public health value of vaccines. Vaccine efficacy provides a measure of proportionate disease reduction, is usually limited to etiologically confirmed dise...
Autores principales: | Wilder-Smith, A., Longini, I., Zuber, P. L., Bärnighausen, T., Edmunds, W. J., Dean, N., Spicher, V. Masserey, Benissa, M. R., Gessner, B. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527440/ https://www.ncbi.nlm.nih.gov/pubmed/28743299 http://dx.doi.org/10.1186/s12916-017-0911-8 |
Ejemplares similares
-
Zika vaccines and therapeutics: landscape analysis and challenges ahead
por: Wilder-Smith, Annelies, et al.
Publicado: (2018) -
The pragmatic, rapid, and iterative dissemination and implementation (PRIDI) cycle: adapting to the dynamic nature of public health emergencies (and beyond)
por: Yousefi Nooraie, Reza, et al.
Publicado: (2021) -
Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science
por: McKenna, Stephen P
Publicado: (2011) -
Patient and public involvement in research: from tokenistic box ticking to valued team members
por: Jackson, Tracy, et al.
Publicado: (2020) -
Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines
por: Fowkes, Freya JI, et al.
Publicado: (2013)